Gelonghui September 6?Qizheng Tibetan Medicine (002287.SZ) held a performance presentation meeting on September 6, 2023 to explain whether it is possible to explain the overall capacity planning of listed companies in 2024 after the new Lintao plant is put into production at the end of the year. The company replied that after the construction project of Qizheng Tibetan medicine industry base was completed, the company increased the production capacity of Qizheng Xiaotong paste by 80 million pieces per year, with a total production capacity of 204 million pieces per year, and the ointment increased production capacity by 22 million pieces per year, with a total production capacity of 39 million pieces per year. A total of 300 million pills were added per year, with a total production capacity of 390 million tablets per year. According to the company's 2024 sales target, the company will ensure the timely supply of multi-product and multi-product sales demand according to the sales target of 2024.
奇正藏药(002287.SZ)：奇正藏药医药产业基地建设项目建成后，公司奇正消痛贴膏新增产能8000万贴/年，总产能达20400万贴/年
Qizheng Tibetan Medicine (002287.SZ): After the Qizheng Tibetan medicine industry base construction project was completed, the company's Qizheng pain relief paste increased production capacity by 80 million pats/year, with a total production capacity of 2
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.